- Category
- Micro (2021-22)
- Udyam number
- UDYAM-UP-15-0016777

Snseren Laboratories Private Limited
About Snseren Laboratories Private Limited
Data last updated:
Snseren Laboratories Private Limited is a private limited company based in Bareilly, Uttar Pradesh, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 14 April 2022.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24290UP2022PTC162428.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Saurabh Singh Gangwar and Ankit Bajpai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 123/4 Kesar Vatika Karamchari Nagar, Bareilly, Uttar Pradesh, India – 243122.
As per the financials filed for FY 2025, the company reported a revenue of ₹68.71 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹5,730 (net margin 0.1%) and EBITDA of ₹2.61 Lakh (EBITDA margin 3.8%).
As per MCA filings, the company has open charges of ₹20 Lakh on record.
Snseren Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-15-0016777). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Snseren Laboratories
Contact details
Snseren Laboratories Private Limited's registered office is in Bareilly, Uttar Pradesh.
- Registered Address123/4 Kesar Vatika Karamchari Nagar, Bareilly, Uttar Pradesh, India – 243122
- IndustryChemicals, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Snseren Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Snseren Laboratories Private Limited, buy the company report.
Financials of Snseren Laboratories Private Limited
FY 2025 filings availableSnseren Laboratories Private Limited reported revenue of ₹68.71 Lakh (up 396% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 396% in the latest year. EBITDA rose 40% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹2.61 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹5,730 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 3.8% | ||
| Net Profit Margin | 0.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Snseren Laboratories Private Limited, buy the company report.
Board of directors of Snseren Laboratories Private Limited
Snseren Laboratories has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saurabh Singh Gangwar | Director | 14 Apr 2022 | 4 Years 6 Months | Current |
| Ankit Bajpai | Director | 14 Apr 2022 | 4 Years 6 Months | Current |
Peer comparison
Snseren Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amazon Drugs Private Limited | ₹68.9 Lakh (FY 2025) | -24.0% | Bangalore, Karnataka, India | |||
| Esskays Pharma Private Limited | ₹68.88 Lakh (FY 2025) | -42.0% | New Delhi, Delhi, India | |||
| Safenetic India Private Limited | ₹68.82 Lakh (FY 2024) | 40.0% | Delhi, India | |||
| Pahlson Agro Chem Private Limited | ₹68.74 Lakh (FY 2021) | -11.0% | Meerut, Uttar Pradesh, India | |||
| Zenobia Pharmaceuticals Private Limited | ₹68.72 Lakh (FY 2021) | -42.0% | Kozhikode, Kerala, India | |||
| Snseren Laboratories Private Limitedthis company | ₹68.71 Lakh (FY 2025) | ₹5,730 | 0.1% | 396.0% | Bareilly, Uttar Pradesh, India | |
| Dotsy Pharmaceuticals Private Limited | ₹68.7 Lakh (FY 2024) | 686991250.0% | New Delhi, Delhi, India | |||
| Shivayur International Marketing Private Limited | ₹68.63 Lakh (FY 2024) | -28.0% | Vadodara, Gujarat, India | |||
| Ray Remedies Private Limited | ₹68.54 Lakh (FY 2025) | -57.0% | Changodar Ahmedabad, Gujarat, India | |||
| Elara Pharmaceuticals Private Limited | ₹68.52 Lakh (FY 2025) | 24.0% | Pune, Maharashtra, India | |||
| Enzed Chloro Products Pvt Ltd | ₹68.47 Lakh (FY 2024) | 10.0% | Saidabad, Hyderabad, Telangana, India |
To see the full peer comparison of Snseren Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Jun 2023 | 100760821 | Canara Bank | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Snseren Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Snseren Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Snseren Laboratories Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Snseren Laboratories Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Ankit Bajpai was appointed as Director on 14 Apr 2022.
Frequently asked questions
Snseren Laboratories is an active private limited company based in Bareilly, Uttar Pradesh, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 14 April 2022 (4+ years old) and is registered under CIN U24290UP2022PTC162428.
Snseren Laboratories has 2 current directors:
- Saurabh Singh Gangwar - Director
- Ankit Bajpai - Director
The latest financial statements of Snseren Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Snseren Laboratories is U24290UP2022PTC162428. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Snseren Laboratories was incorporated on 14 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Snseren Laboratories by revenue are Amazon Drugs Private Limited, Esskays Pharma Private Limited, Safenetic India Private Limited, Pahlson Agro Chem Private Limited, Zenobia Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ankit Bajpai was appointed as Director on 14 Apr 2022. Saurabh Singh Gangwar was appointed as Director on 14 Apr 2022.
Yes, Snseren Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-15-0016777).
The registered office of Snseren Laboratories is at 1234 Kesar Vatika Karamchari Nagar, Bareilly, Uttar Pradesh, India – 243122.
Snseren Laboratories operates in the chemicals industry, in the other chemical product segment.
Snseren Laboratories has open charges of ₹20 Lakh and no satisfied charges on record as per latest MCA filings.

